MEDOR: device for analyzing volatile organic compounds for early cancer diagnosis using mass spectrometry.

SATT NORD



06 Octobre 2025

Partager sur facebook Partager sur twitter Partager sur linkedin Partager sur google+

Fields

Biology / Medical

Sectors

Health

The Medor medical device uses mass spectrometry to detect the volatile organic compounds (VOCs) that reflect our pathophysiological state.

The 1st POC is on the detection of breast cancer from VOCs Non-invasively and painlessly using wipes or swabs (exhaled air, sweat, tears, blood, urine).

 Possible applications in a variety of pathologies

Cancer, health, food, forensics, environment

Download the offer Download the offer

Newsletter